AC Immune SA (ACIU)

NASDAQ: ACIU · IEX Real-Time Price · USD
5.00
+0.16 (3.31%)
At close: Dec 29, 2023, 4:00 PM
5.07
+0.07 (1.40%)
After-hours: Dec 29, 2023, 7:23 PM EST

Total Valuation

AC Immune has a market cap or net worth of $493.75 million. The enterprise value is $401.63 million.

Market Cap 493.75M
Enterprise Value 401.63M

Important Dates

The last earnings date was Friday, November 3, 2023, before market open.

Earnings Date Nov 3, 2023
Ex-Dividend Date n/a

Share Statistics

AC Immune has 98.75 million shares outstanding.

Shares Outstanding 98.75M
Owned by Insiders (%) 45.62%
Owned by Institutions (%) 23.70%
Float 38.29M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 454,229.07
Forward PS 21.20
PB Ratio 3.31
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 369,487.09
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.36, with a Debt / Equity ratio of 0.02.

Current Ratio 7.36
Quick Ratio 6.86
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -456.90

Financial Efficiency

Return on equity (ROE) is -46.50% and return on invested capital (ROIC) is -53.71%.

Return on Equity (ROE) -46.50%
Return on Assets (ROA) -41.70%
Return on Capital (ROIC) -53.71%
Revenue Per Employee $9
Profits Per Employee -$588,665
Employee Count 126
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, AC Immune has paid $13,069 in taxes.

Income Tax 13,069
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +173.22% in the last 52 weeks. The beta is 0.72, so AC Immune's price volatility has been lower than the market average.

Beta (1Y) 0.72
52-Week Price Change +173.22%
50-Day Moving Average 3.35
200-Day Moving Average 2.78
Relative Strength Index (RSI) 80.38
Average Volume (30 Days) 90,666

Short Selling Information

Short Interest 496,392
Short Previous Month 511,685
Short % of Shares Out 1.07%
Short % of Float n/a
Short Ratio (days to cover) 4.24

Income Statement

In the last 12 months, AC Immune had revenue of $1,087 and -$74.17 million in losses. Loss per share was -$0.97.

Revenue 1,087
Gross Profit 1,188
Operating Income -81.71M
Pretax Income -81.06M
Net Income -74.17M
EBITDA -78.19M
EBIT -80.88M
Loss Per Share -$0.97
Full Income Statement

Balance Sheet

The company has $94.96 million in cash and $2.84 million in debt, giving a net cash position of $92.11 million or $0.93 per share.

Cash & Cash Equivalents 94.96M
Total Debt 2.84M
Net Cash 92.11M
Net Cash Per Share $0.93
Equity / Book Value 149.30M
Book Value Per Share 1.51
Working Capital 88.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.45 million and capital expenditures -$803,124, giving a free cash flow of -$74.26 million.

Operating Cash Flow -73.45M
Capital Expenditures -803,124
Free Cash Flow -74.26M
FCF Per Share -$0.88
Full Cash Flow Statement

Margins

Gross margin is 109.30%, with operating and profit margins of -7,517,416.15% and -6,823,527.05%.

Gross Margin 109.30%
Operating Margin -7,517,416.15%
Pretax Margin -7,456,975.16%
Profit Margin -6,823,527.05%
EBITDA Margin -7,193,133.31%
EBIT Margin -7,440,689.98%
FCF Margin -6,831,471.05%

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -15.02%
FCF Yield -15.04%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.18%
Shareholder Yield -0.18%

Analyst Forecast

The average price target for AC Immune is $16.00, which is 220.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.00
Price Target Difference 220.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 109.06%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AC Immune has an Altman Z-Score of 10.41 and a Piotroski F-Score of 3.

Altman Z-Score 10.41
Piotroski F-Score 3